Understanding how splicing affects blood stem cell development in myelodysplastic syndrome.
Crosstalk of Splicing and Signaling in HSPC fate choices
This study is looking at how changes in RNA splicing affect the development of blood stem cells and how these changes can lead to myelodysplastic syndrome (MDS), with the hope of finding new treatments for people with this condition.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Albert Einstein College of Medicine NIH-funded |
| Lab location | 1 site (Bronx, United States) |
| Project ID | NIH-10661557 on NIH RePORTER |
What this research studies
This research investigates the role of RNA splicing in the development of hematopoietic stem and progenitor cells (HSPCs) and how their dysfunction contributes to myelodysplastic syndrome (MDS). By studying the molecular mechanisms that regulate splicing in these cells, the researchers aim to uncover how specific mutations in splicing factors lead to ineffective blood cell production and related complications. The approach includes using zebrafish models to observe the effects of splicing factor mutations on HSPC formation and signaling pathways. The ultimate goal is to identify new therapeutic targets for treating patients with MDS.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals diagnosed with myelodysplastic syndrome or related blood disorders.
Not a fit: Patients with other types of blood disorders not related to splicing factor mutations may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to novel treatments for myelodysplastic syndrome, improving blood cell production and patient outcomes.
How similar studies have performed: Previous research has shown promising results in understanding splicing mechanisms in other blood disorders, suggesting potential for success in this area as well.
Where this research is happening
Bronx, United States
- Albert Einstein College of Medicine — Bronx, United States (Active)
Researchers
- Principal investigator: Bowman, Teresa V — Albert Einstein College of Medicine
- Study coordinator: Bowman, Teresa V
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.